advertisement
Singh K 22
Showing records 1 to 22 | Display all abstracts from Singh K118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
Samuelson TW
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North India
Singh K
Indian Journal of Ophthalmology 2024; 72: 391-396
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Sun MT
Ophthalmology science 2024; 4: 100448
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North India
Singh A
Indian Journal of Ophthalmology 2024; 72: 391-396
118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
De Francesco T
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Cotton RM
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
Ahmed IIK
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North India
Jain D
Indian Journal of Ophthalmology 2024; 72: 391-396
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Charoenkijkajorn C
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
Gedde SJ
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Garcia-Sanchez J
Ophthalmology science 2024; 4: 100448
118001 Factors affecting adherence to glaucoma medication: Patient perspective from North India
Verma V
Indian Journal of Ophthalmology 2024; 72: 391-396
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Dalal R
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
Paranjpe VR
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Xia X
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
Singh K
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Lin JH
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
Brubaker JW; Grover DS
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Singh K
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
Fellman RL
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117463 Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery: A Pilot Study
Goldberg JL; Liu WW
Ophthalmology science 2024; 4: 100448
118281 Difficult decisions, filtration surgery, and the heartbreak of the numerator
Zhang AD; Barton K
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
